Piper Sandler ups Intra-Cellular to chubby, cites Caplyta potential Source: Seekingalpha
Browsing: potential
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Allurion started at buy by Roth MKM over weight-loss device potential Source: Seekingalpha
Piper Sandler ups Intra-Cellular to obese, cites Caplyta potential Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Allurion started at buy by Roth MKM over weight-loss device potential Source: Seekingalpha
Zimmer Biomet falls on potential revenue hit from software issue Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
NRx Pharmaceuticals reports potential acquisition and financing agreements Source: Seekingalpha
NRx Pharmaceuticals reports potential acquisition and financing agreements Source: Seekingalpha